Victor Vargas, MD; Luis Castells, MD; Juan I. Esteban, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Although evidence implicates the hepatitis B virus in the pathogenesis of hepatocellular carcinoma (1), other factors such as alcohol or chronic infection by non-A, non-B hepatitis agents have also been implicated, particularly in developed countries. Several documented cases of hepatocellular carcinoma following chronic non-A, non-B hepatitis have been reported in developed countries (2).
The isolation of the major bloodborne non-A, non-B hepatitis agent, hepatitis C virus (HCV), by cloning (3) has led to the development of assays for the detection of specific antibodies (4). In a previous report (5), we showed that HCV infection is present in
Vargas V, Castells L, Esteban JI. High Frequency of Antibodies to the Hepatitis C Virus among Patients with Hepatocellular Carcinoma. Ann Intern Med. 1990;112:232–233. doi: 10.7326/0003-4819-112-3-232_2
Download citation file:
Published: Ann Intern Med. 1990;112(3):232-233.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use